This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
RABBIT ANTI HUMAN CD289
catalog :
AHP1022
quantity :
0.1 mg
price :
350 USD
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human
application :
western blot
product information
Entity Type :
Polyclonal Antibody
Entity Category :
Antibodies
ProductCode :
AHP1022
Description :
RABBIT ANTI HUMAN CD289
Specificity :
CD289
TargetSpecies :
Human
Host :
Rabbit
Format :
Purified
Isotypes :
Polyclonal IgG
Applications :
C,WB
ApplicationTypes :
Western Blotting,Immunohistology - Frozen
Cross Reactivities :
Mouse,Rat
Quantity :
0.1 mg
Quantity Value :
0.1
Quantity Type :
mg
GO Accessions :
GO:0005764,GO:0042742,GO:0002237,GO:0032088,GO:0032009,GO:0030277,GO:0016324,GO:0016323,GO:0010552,GO:0010008,GO:0008543,GO:0008286,GO:0007252,GO:0006954,GO:0005789,GO:0005149,GO:0004888,GO:0005576,GO:0016021,GO:0051770,GO:0051092,GO:0050729,GO:0046330,GO:0045359,GO:0045356,GO:0045087,GO:0045078,GO:0043507,GO:0043123,GO:0042346,GO:0035197,GO:0034123,GO:0034122,GO:0032760,GO:0032757,GO:0032755,GO:0032741,GO:0032735,GO:0032733,GO:0032728,GO:0032722,GO:0032717,GO:0032715
GOTerms :
response to bacteria associated molecule,response to bacterial associated molecule,response to bacterium associated molecule,antibacterial peptide activity,defence response to bacteria,defence response to bacterium,defense response to bacteria,GO:0042830,transmembrane,extracellular,GO:0004926,non G protein coupled 7TM receptor activity,non-G-protein coupled 7TM receptor activity,non-G-protein-coupled 7TM receptor activity,IL-1,interleukin-1 receptor ligand,ER membrane,daf-2 receptor signaling pathway,insulin receptor signalling pathway,FGF receptor signaling pathway,FGF receptor signalling pathway,FGFR signaling pathway,fibroblast growth factor receptor signalling pathway,early phagocytic vesicle,inhibition of NF-kappaB transcription factor,NF-kappaB inhibitor,down regulation of interleukin-6 production,down-regulation of interleukin-6 production,downregulation of interleukin-6 production,inhibition of interleukin-6 production,negative regulation of IL-6 production,down regulation of interleukin-8 production,down-regulation of interleukin-8 production,downregulation of interleukin-8 production,inhibition of interleukin-8 production,negative regulation of IL-8 production,activation of chemokine production,stimulation of chemokine production,up regulation of chemokine production,upregulation of chemokine production,up-regulation of chemokine production,activation of interferon-beta production,positive regulation of IFN-beta production,stimulation of interferon-beta production,up regulation of interferon-beta production,up-regulation of interferon-beta production,upregulation of interferon-beta production,activation of interleukin-10 production,positive regulation of IL-10 production,stimulation of interleukin-10 production,up regulation of interleukin-10 production,up-regulation of interleukin-10 production,upregulation of interleukin-10 production,activation of interleukin-12 production,positive regulation of IL-12 production,stimulation of interleukin-12 production,up regulation of interleukin-12 production,up-regulation of interleukin-12 production,upregulation of interleukin-12 production,activation of interleukin-18 production,positive regulation of IL-18 production,stimulation of interleukin-18 production,up regulation of interleukin-18 production,up-regulation of interleukin-18 production,upregulation of interleukin-18 production,activation of interleukin-6 production,positive regulation of IL-6 production,stimulation of interleukin-6 production,up regulation of interleukin-6 production,up-regulation of interleukin-6 production,upregulation of interleukin-6 production,activation of interleukin-8 production,positive regulation of IL-8 production,stimulation of interleukin-8 production,up regulation of interleukin-8 production,up-regulation of interleukin-8 production,upregulation of interleukin-8 production,activation of tumor necrosis factor production,positive regulation of TNF production,positive regulation of TNF-alpha production,positive regulation of tumor necrosis factor-alpha production,stimulation of tumor necrosis factor production,up regulation of tumor necrosis factor production,upregulation of tumor necrosis factor production,up-regulation of tumor necrosis factor production,negative regulation of TLR signaling pathway,negative regulation of toll-like receptor signalling pathway,positive regulation of TLR signaling pathway,positive regulation of toll-like receptor signalling pathway,small interfering RNA binding,activation of NF-kappaB import into nucleus,positive regulation of NF-kappaB import into cell nucleus,positive regulation of NF-kappaB transport from cytoplasm to nucleus,positive regulation of NF-kappaB-nucleus import,stimulation of NF-kappaB import into nucleus,up regulation of NF-kappaB import into nucleus,up-regulation of NF-kappaB import into nucleus,upregulation of NF-kappaB import into nucleus,activation of I-kappaB kinase/NF-kappaB cascade,stimulation of I-kappaB kinase/NF-kappaB cascade,up regulation of I-kappaB kinase/NF-kappaB cascade,up-regulation of I-kappaB kinase/NF-kappaB cascade,upregulation of I-kappaB kinase/NF-kappaB cascade,positive regulation of JUNK activity,stimulation of JNK activity,up regulation of JNK activity,upregulation of JNK activity,up-regulation of JNK activity,activation of interferon-gamma biosynthetic process,positive regulation of interferon-gamma anabolism,positive regulation of interferon-gamma biosynthesis,positive regulation of interferon-gamma formation,positive regulation of interferon-gamma synthesis,stimulation of interferon-gamma biosynthetic process,up regulation of interferon-gamma biosynthetic process,up-regulation of interferon-gamma biosynthetic process,upregulation of interferon-gamma biosynthetic process,GO:0002226,nonspecific immune response,activation of interferon-alpha biosynthetic process,positive regulation of interferon-alpha anabolism,positive regulation of interferon-alpha biosynthesis,positive regulation of interferon-alpha formation,positive regulation of interferon-alpha synthesis,stimulation of interferon-alpha biosynthetic process,up regulation of interferon-alpha biosynthetic process,up-regulation of interferon-alpha biosynthetic process,upregulation of interferon-alpha biosynthetic process,activation of interferon-beta biosynthetic process,positive regulation of interferon-beta anabolism,positive regulation of interferon-beta biosynthesis,positive regulation of interferon-beta formation,positive regulation of interferon-beta synthesis,stimulation of interferon-beta biosynthetic process,up regulation of interferon-beta biosynthetic process,up-regulation of interferon-beta biosynthetic process,upregulation of interferon-beta biosynthetic process,activation of JNK cascade,stimulation of JNK cascade,up regulation of JNK cascade,upregulation of JNK cascade,up-regulation of JNK cascade,activation of inflammatory response,stimulation of inflammatory response,up regulation of inflammatory response,upregulation of inflammatory response,up-regulation of inflammatory response,activation of NF-kappaB,activation of NF-kappaB transcription factor,NF-kappaB activation,activation of nitric-oxide synthase biosynthetic process,positive regulation of NO synthase biosynthesis,positive regulation of NO synthase biosynthetic process,positive regulation of NOS biosynthesis,positive regulation of NOS biosynthetic process,stimulation of nitric-oxide synthase biosynthetic process,up regulation of nitric-oxide synthase biosynthetic process,up-regulation of nitric-oxide synthase biosynthetic process,upregulation of nitric-oxide synthase biosynthetic process
Uniprot Accessions :
Q9NR96
Gene :
TLR9
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=54106
Published Synonyms :
TLR9
Entity Formats :
Purified
UNSPSC :
41116161
Concentration :
IgG concentration 1.0mg/ml
Product Form :
Purified IgG - liquid
PriceGBP :
250
PriceEUR :
350
PriceUSD :
350 USD
PriceCHF :
381
PriceSEK :
3815
PriceNOK :
3834
PriceDKK :
2609
company information

Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
questions and comments